E
Elizabeth A. Maher
Researcher at University of Texas Southwestern Medical Center
Publications - 94
Citations - 12511
Elizabeth A. Maher is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Glioma & Cancer. The author has an hindex of 39, co-authored 89 publications receiving 10966 citations. Previous affiliations of Elizabeth A. Maher include Harvard University.
Papers
More filters
Journal ArticleDOI
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim,Craig H. Mermel,Craig H. Mermel,Dale Porter,Guo Wei,Soumya Raychaudhuri,Soumya Raychaudhuri,Jerry Donovan,Jordi Barretina,Jordi Barretina,Jesse S. Boehm,Jennifer Dobson,Jennifer Dobson,Mitsuyoshi Urashima,Kevin T. Mc Henry,Reid M. Pinchback,Azra H. Ligon,Yoon Jae Cho,Leila Haery,Leila Haery,Heidi Greulich,Michael R. Reich,Wendy Winckler,Michael S. Lawrence,Barbara A. Weir,Barbara A. Weir,Kumiko E. Tanaka,Kumiko E. Tanaka,Derek Y. Chiang,Derek Y. Chiang,Derek Y. Chiang,Adam J. Bass,Adam J. Bass,Adam J. Bass,Alice Loo,Carter Hoffman,Carter Hoffman,John R. Prensner,John R. Prensner,Ted Liefeld,Qing Gao,Derek Yecies,Sabina Signoretti,Sabina Signoretti,Elizabeth A. Maher,Frederic J. Kaye,Hidefumi Sasaki,Joel E. Tepper,Jonathan A. Fletcher,Josep Tabernero,José Baselga,Ming-Sound Tsao,Francesca Demichelis,Mark A. Rubin,Pasi A. Jänne,Pasi A. Jänne,Mark J. Daly,Mark J. Daly,Carmelo Nucera,Ross L. Levine,Benjamin L. Ebert,Benjamin L. Ebert,Benjamin L. Ebert,Stacey Gabriel,Anil K. Rustgi,Cristina R. Antonescu,Marc Ladanyi,Anthony Letai,Levi A. Garraway,Levi A. Garraway,Massimo Loda,Massimo Loda,David G. Beer,Lawrence D. True,Aikou Okamoto,Scott L. Pomeroy,Samuel Singer,Todd R. Golub,Todd R. Golub,Todd R. Golub,Eric S. Lander,Eric S. Lander,Eric S. Lander,Gad Getz,William R. Sellers,Matthew Meyerson,Matthew Meyerson +86 more
TL;DR: It is demonstrated that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival, and a large majority of SCNAs identified in individual cancer types are present in several cancer types.
Journal ArticleDOI
Malignant glioma: Genetics and biology of a grave matter
Elizabeth A. Maher,Frank B. Furnari,Robert M. Bachoo,David H. Rowitch,David N. Louis,Webster K. Cavenee,Ronald A. DePinho +6 more
TL;DR: Although a comprehensive view of the genetic lesions encountered in malignant gliomas has been compiled, substantive conceptual and practical barriers remain in assigning functional significance to these genetic changes and in harnessing this basic information into the development of drugs that make a difference in patient care.
Journal ArticleDOI
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.
Robert M. Bachoo,Elizabeth A. Maher,Keith L. Ligon,Norman E. Sharpless,Suzanne S Chan,Mingjian James You,Yi Tang,Jessica DeFrances,Elizabeth H. Stover,Ralph Weissleder,David H. Rowitch,David N. Louis,Ronald A. DePinho +12 more
TL;DR: These data support the view that dysregulation of specific genetic pathways, rather than cell-of-origin, dictates the emergence and phenotype of high-grade gliomas and provide evidence that p16(INK4a) and p19(ARF) synergize to maintain terminal astrocyte differentiation.
Journal ArticleDOI
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
Changho Choi,Sandeep K. Ganji,Ralph J. DeBerardinis,Kimmo J. Hatanpaa,Dinesh Rakheja,Dinesh Rakheja,Zoltan Kovacs,Xiao Li Yang,Tomoyuki Mashimo,Jack M Raisanen,Isaac Marin-Valencia,Juan M. Pascual,Christopher J. Madden,Bruce E. Mickey,Craig R. Malloy,Robert Bachoo,Elizabeth A. Maher +16 more
TL;DR: In this article, a non-invasive detection of 2-hydroxyglutarate (2HG) by proton magnetic resonance spectroscopy (MRS) was reported.
Journal ArticleDOI
Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases
Tomoyuki Mashimo,Kumar Pichumani,Vamsidhara Vemireddy,Kimmo J. Hatanpaa,Dinesh K. Singh,Shyam Sirasanagandla,Suraj Nannepaga,Sara Grazia Maria Piccirillo,Zoltan Kovacs,Chan Foong,Zhiguang Huang,Samuel L. Barnett,Bruce E. Mickey,Ralph J. DeBerardinis,Benjamin P. Tu,Elizabeth A. Maher,Robert Bachoo +16 more
TL;DR: The data demonstrate a strikingly common metabolic phenotype in diverse brain tumors that includes the ability to oxidize acetate in the citric acid cycle, which may be important for meeting the high biosynthetic and bioenergetic demands of malignant growth.